Cafepharma Today

December 11 2024 - With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033
With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033
Walgreens shares surge on reported talks to be taken private
How Trump’s second term will affect the medtech industry
Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Amylin, Eli Lilly to Address Byetta Concerns
TheStreet.com
Tuesday, August 26, 2008 - 6:11am
tags:
[video]Gurus Buy Amgen, Sell Shire
Forbes
Monday, August 25, 2008 - 5:33pm
tags:
Two Ways To Play: Merck Cured of Negative Outlook
Minyanville
Monday, August 25, 2008 - 5:24pm
tags:
Lipitor Marketing Raises Blood Pressure
Motley Fool
Monday, August 25, 2008 - 4:33pm
tags:
Merck Rating Outlook Raised to Stable, by Moody's
Bloomberg
Monday, August 25, 2008 - 3:57pm
tags:
Cell Therapeutics Changes Its Ways
Forbes
Monday, August 25, 2008 - 3:41pm
tags:
Alpharma Buyout Offer to Raise
Yahoo/Zacks.com
Monday, August 25, 2008 - 3:26pm
tags:
Applied Biosystems sets vote on $6.7B Invitrogen deal
Bizjournals.com
Monday, August 25, 2008 - 2:55pm
tags:
Brodsky & Smith, LLC Announces Investigation of Wyeth Corp. for Violation of Federal Securities Laws
Yahoo
Monday, August 25, 2008 - 2:09pm
tags:
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Trading Markets
Monday, August 25, 2008 - 2:06pm
tags:
Merck Report Could Alter Clinical Trials, Marketing
Clinical Trials Today
Monday, August 25, 2008 - 2:03pm
tags:
Moody's Investors Service affirms King Pharmaceuticals rating in wake of buyout proposal
Yahoo/AP
Monday, August 25, 2008 - 2:01pm
tags:
Azur Sues Barr to Block Generic Form of Schizophrenia Drug
Bloomberg
Monday, August 25, 2008 - 2:00pm
tags:
AstraZeneca's Flu Campaign Season Begins
CNBC
Monday, August 25, 2008 - 1:50pm
tags:
Will FDA label regs shield pharma?
Fierce Pharma
Monday, August 25, 2008 - 11:39am
tags:
Genzyme to help pursue malaria research
Bizjournals.com
Monday, August 25, 2008 - 11:12am
tags:
Early Glance: Biotechnology companies
Yahoo/AP
Monday, August 25, 2008 - 10:56am
tags:
Amgen is poised for higher opening following approval of rare blood-clotting disorder drug
Yahoo/AP
Monday, August 25, 2008 - 9:16am
tags:
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Yahoo
Monday, August 25, 2008 - 7:48am
tags:
Glaxo's HIV-Drug Ads Draw Critics
WSJ Online
Monday, August 25, 2008 - 6:06am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (rerun)
Drug Channels
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating (rerun)
Drug Channels
Infant RSV Vaccination Trouble
In the Pipeline
The BioSecure Act Falters?
In the Pipeline
Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble? (rerun)
Drug Channels
Computational Care
In the Pipeline
The Rings Less Traveled
In the Pipeline
Now That's What I Call Disordered
In the Pipeline
Do They Even Bind?
In the Pipeline

Latest Jobs

Virtual Biopharma Sales Specialist
Raleigh, North Carolina, 27601
Syneos Health/ inVentiv Health Commercial LLC
Pharmaceutical Sales Customer Engagement - Santa Rosa, CA
Santa Rosa, California,
Otsuka
Portfolio Sales Specialist - North Dakota / South Dakota / Nebraska
Lincoln, Nebraska, 68511
ICU Medical
Bilingual Business Development Representative
Kennedy Space Center, Florida
Complete Care
Business Development Manager, Facial - Chevy Chase, MD
Chevy Chase, Maryland, 20815
AbbVie
Virtual Biopharma Sales Specialist
Dallas, Texas, 75215
Syneos Health/ inVentiv Health Commercial LLC
Regional Director, Central Baltimore, Maryland, United States
Baltimore, Maryland, 21276
TBWA\Chiat\Day
Account Executive
San Antonio, Texas, 78208
Elara Caring
Nobel Biocare Regional Manager - Mid Atlantic
Washington, District of Columbia, 20022
enVista
Senior Manager, Professional Affairs (Northeast)
Jersey City, New Jersey, 07390
Bausch + Lomb
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information